- Dr Andrew Rickman OBE
- - Chairman
- David Brister
- - Director (Oxford Capital)
- Dr Victor Christou
- - Director (Carbon Trust)
- Reenie McCarthy
- - Director (Morningside Group)
- Claude Stoufs
- - Director (Capricorn Venture Partners)
- Thomas Grote, CFO
- - Director (ConVergInce Holdings)
- Dr Edward Green, Founder & CSO
- - Director
- Joel Stone
- - President, North America and Global Vice President, Engineering
- Sean Sutcliffe, CEO
- - Director
Dr Andrew Rickman OBE (Chairman)
Andrew is the Chairman of GBL. He founded Nasdaq-listed Bookham Inc., (now Oclaro) the world's largest producer of telecoms fiber optic communication components and sub-systems and brings to GBL extensive experience of growing a global technology business and extensive business experience in China. He is founder and Chairman of Rockley Group, an investment organization focused on developing technology-based businesses. Andrew has a Mechanical Engineering Degree from Imperial College London, a Ph.D. in Photonics from Surrey University and an MBA from Cranfield University, as well as honorary doctorates from Surrey, Kingston and Edinburgh Napier Universities. He is an honorary Professor, SIMIT, Chinese Academy of Sciences. Andrew has held advisory board positions with the East Asia Institute of the University of Cambridge and Hong Kong Applied Science and Technology Research Institute Limited. He was awarded an OBE in the Queen's Millennium Honours list for services to the telecommunications industry and is a winner of the prestigious Royal Academy of Enginneering Silver Medal for his outstanding contribution to British engineering.
David Brister - Director (Oxford Capital Partners)
David is an Operating Partner with Oxford Capital Partners, who led GBL's Series A round of financing. He has more than 20 years of investment experience including venture capital and private equity, including 14 years in biotechnology venture capital. He has participated in the funding of more than 100 deals in his career. David is the Chairman of Aitua Limited. He also serves as a Member of Supervisory Board at AM-Pharma BV, Crysalin Limited, Optimal Medicine Ltd, and Veryan Limited. He served as a Chairman of Domantis. Mr.Brister was a Director of Etiologics Limited and Xention Limited. He holds a B.Sc. degree, with honors, in Genetics and Zoology from Sheffield University in the UK.
Dr. Victor Christou - Director (Carbon Trust Investments)
Victor is a Venture Partner at CT Investment Partners LLP, the venture capital advisor to the Carbon Trust. Before joining CT Investment Partners LLP, he was with Oxford Capital Partners, where he led the Series A round investment in GBL in 2007. Prior to his career in venture capital, Victor was a successful entrepreneur and a Royal Society University Research Fellow and Lecturer at the University of Oxford. He holds a BsC (Honors) and a Ph.D. in Chemistry from Imperial College and was a Sloan Fellow at the Graduate School of Business, Stanford University.
Reenie McCarthy, Esquire - Director (Morningside)
Reenie has represented Morningside since 1993 and has extensive experience with venture-backed biotechnology companies. Morningside is a diversified investment group with investments in North America, Europe, across Asia Pacific, and since 1992, in Mainland China. Reenie received her A.B. (cum laude) from Bates College and her J.D. from the University of Pennsylvania Law School. Prior to joining Morningside in 1993, Reenie was with Richards & O'Neill (now Bingham McCutcheon LLP) in New York. She currently represents Morningside on several private company boards.
Claude Stoufs - Director (Capricorn Venture Partners)
Claude is Senior Investment Manager for Capricorn Venture Partners since 2000. He is also a Senior Investment Manager for Capricorn's Cleantech Fund, who led GBL's Series B round of financing. Prior to joining Capricorn, Claude held management positions with FMC Corp, Occidental Chemical, PA Technology, Fabelta, and Akzo. Claude serves or has served at the Board of Directors of BioAlliance, Elbion / 4AZA, TiGenix, UroGene, FlandersBiovzw, Fluxome, Alaska Food Diagnostics, AK Diagnostics Europe, Avantium, FRX Polymers, Green Biologics, Capricorn Venture Fund II and Capricorn Cleantech Fund. Claude holds an M.Sc. in Chemistry from University of Brussels and is a graduate in Business Administration and International Trade from the University of Brussels.
Thomas Grote, CFO - Director (ConVergInce Holdings)
Thomas Grote serves as our Chief Financial Officer. Thomas served as Chief Operating Officer of Donatos Pizza, a Grote family business, and was instrumental in expanding the company into a regional chain, which was purchased by McDonald's Corporation in 1999. Thomas assisted with the buy-back of Donato's from McDonald's in 2003. Thomas is an investor in the Ohio Tech Angel Fund and serves on the board of directors of the Grote Company, a global manufacturer of specialized food processing equipment. He is a board director for Renewable Lubricants, an Ohio bio-based lubricant company. He also serves on the board of trustees for the Central Ohio United Way and Miami University of Ohio. Thomas earned a B.S. in finance from Miami University of Ohio and an MBA from the Wharton School at the University of Pennsylvania.
Dr Edward Green, Founder & CSO - Director
Edward gained a Ph.D. in Biochemical Engineering from the University of Manchester Institute of Science and Technology (UMIST) in 1993. Edward spent five years in academia at Rice University, Texas, US and at Gothenburg University, Sweden developing novel microbes for biofuels and chemicals. In 1998, he joined Agrol Ltd., a UK start up where he established a multi-disciplinary team that developed a high temperature ethanol process. In 2003 he founded GBL. Edward's efforts were recognized in the inaugural Woods Enterprise Awards for Entrepreneurship. Edward has delivered technical improvements in microbial fermentation processes for biofuel production over the past 20 years contributing to numerous scientific publications and patents.
Joel Stone - President, North America and Global Vice President, Engineering
Joel has responsibility for all operations in North America as well as global responsibility for engineering and scale up of commercial production. Prior to his current role, Joel was CEO of butylfuel™ Inc. His previous roles include COO of Osage Bio Energy, COO at AS Alliances Biofuels, COO at Abengoa Bioenergy Corporation, VP Operations for Balchem, and VP of Operations for Opta Food Ingredients. Early in his career he was Director of Manufacturing for Genencor, and he spent several years with A.E. Staley. His 30-year experience includes bringing on 400MM GPY of ethanol at Osage, AS Alliances, Abengoa and Staley. Joel earned a B.S. degree in chemical engineering from the Virginia Polytechnic University and an M.S. in chemical and biochemical engineering from the University of Pennsylvania. He serves on the Technical Advisory Committee for the National Corn to Ethanol Research Center.
Sean Sutcliffe, CEO - Director
Sean Sutcliffe has been Chief Executive of Green Biologics since April 2008, contributing to the company extensive commercial and operational experience across the energy and renewables sector. Prior to joining Green Biologics he was from 2005 Chief Executive of Biofuels Corporation, a UK based biodiesel producer, and from 2007 Chairman of Tidal Generation Limited, a developer of tidal stream devices. Previously Sean worked for BG Group Plc. for 14 years in a variety of roles spanning operations, business development and strategy, most recently as Executive Vice President with responsibility for Corporate Development and New Businesses. Sean is a Chartered Mechanical Engineer with an Engineering degree from Cambridge University and is a Non-Executive Director of You Broadband, an Indian ISP, and a trustee of Practical Action, an international development charity.